Published in Hepatitis Weekly, April 19th, 1999
The Red Cross is investigating a genetic test - nucleic acid testing or NAT - for the early detection of transfusion-transmitted viruses, such as HIV and hepatitis C virus (HCV), at its National Genome Testing Laboratory in San Diego, California.
Already the Red Cross' use of NAT has detected the first unit of HCV infected donor blood that was negative by standard screening tests, thus preventing a probable transmission of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly